We are proud to share our latest contribution to the #Covid_19 mRNA vaccine field. A #SARSCoV2-hFc-Conjugated RBD mRNA Vaccine Delivered via Lipid Nanoparticles @acsnano. https://t.co/yRbrEoehZJ
Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered Lipid Nanoparticles.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2021 – Nov 2021Where it's discussed
-
X / Twitter19 posts
-
News3 articles
-
YouTube2 videos
-
Reddit2 posts
-
Blogs2 articles
AI synopsis
What people are saying
The collective discussions highlight the significance of vaccine design leveraging lipid nanoparticles and the immune responses observed, such as neutralizing antibodies, demonstrating a keen scientific interest. The tone balances technical detail with cautious optimism, indicating both engagement with the implications and acknowledgment of ongoing debates around nanoparticle safety and vaccine efficacy.
Most discussions recognize the significance of the vaccine design and its potential for effective immune responses, showing a general consensus of support.
Participants display moderate interest, engaging with technical details like lipid nanoparticles and immune responses, though some remain cautious or inquisitive.
Comments include references to immune mechanisms, such as neutralizing antibodies and Th1 responses, indicating active engagement with the scientific content.
The discussions suggest that the research could influence future vaccine development and public health strategies, reflecting a moderate impact outlook.
Abstract in brief
- SARS-CoV-2 is the virus responsible for COVID-19, which has caused over a million deaths globally, highlighting the urgent need for a vaccine.
- Researchers are developing mRNA vaccines as a fast and effective approach, utilizing lipid nanoparticles to deliver the vaccine's key protein component.
- In animal studies, the mRNA vaccine induced a strong immune response, suggesting that this platform is a promising option for creating effective COVID-19 vaccines.
Top posts
Most liked on X and Bluesky@RolandBakerIII @batmulder @JHorrn @UK_Centrist @EllieJellie2020 @RicardLopez123 @Parsifaler @w_mccairn Following work may give some idea: https://t.co/l9ynHfLr77
Una interesante disertación del Dr. Juan José Arango acerca de la preocupación existente sobre las nanopartículas lipídicas en las vacunas con RNAm, las de Pfizer y Moderna.
https://t.co/SlmDb76Xbt
@TrollTemporary @YPotjer Een wat meer technische studie: https://t.co/f4bhaOokiV
El diseño de una nueva vacuna basada en mRNA de RBD-hFc de SARS-CoV-2 deliberada en nano partículas de lípidos muestra una robusta respuesta inmune. Esta origina anticuerpos neutralizantes y respuesta Th1 en ratones BALB/c. | ACS Nano https://t.co/fGohYwGAhh
All mentions
Understanding Lipid Nanoparticles in COVID-19 mRNA Vaccines
In recent days, the topic of lipid nanoparticles encapsulating mRNA in Moderna and Pfizer vaccines has gained attention. This analysis clarifies the science behind these vaccines, addressing concerns and debunking…
Lipid Nanoparticles in COVID-19 mRNA Vaccine Development
This video explains the role of lipid nanoparticles in delivering mRNA vaccines against SARS-CoV-2, highlighting their importance in eliciting a strong immune response and advancing COVID-19 vaccine technology.
@DuseLu @FilipovLukas @VojtechGibis A k tem LPN formulated lucipherase je jeden článek např zde v časopise od ACS: Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles https://t.co/3FTYCkF1gc
@TrollTemporary @YPotjer Een wat meer technische studie: https://t.co/f4bhaOokiV
RT @OezguerYalcin: @RolandBakerIII @batmulder @JHorrn @UK_Centrist @EllieJellie2020 @RicardLopez123 @Parsifaler @w_mccairn Following work m…
https://t.co/SlmDb76Xbt
RT @Johnbo100: Una interesante disertación del Dr. Juan José Arango acerca de la preocupación existente sobre las nanopartículas lipídicas…
RT @Johnbo100: Una interesante disertación del Dr. Juan José Arango acerca de la preocupación existente sobre las nanopartículas lipídicas…
Una interesante disertación del Dr. Juan José Arango acerca de la preocupación existente sobre las nanopartículas lipídicas en las vacunas con RNAm, las de Pfizer y Moderna.
¿DUDA DE LAS VACUNAS? │ NO DEBERÍA https://t.co/Exg2EECKfr vía @YouTube
¿DUDA DE LAS VACUNAS? │ NO DEBERÍA es el nombre del último video que he subido a mi canal de YouTube, jjarango2. https://t.co/y6n3Jilcic
@RolandBakerIII @batmulder @JHorrn @UK_Centrist @EllieJellie2020 @RicardLopez123 @Parsifaler @w_mccairn Following work may give some idea: https://t.co/l9ynHfLr77
RT @ja_regla: El diseño de una nueva vacuna basada en mRNA de RBD-hFc de SARS-CoV-2 deliberada en nano partículas de lípidos muestra una ro…
RT @ja_regla: El diseño de una nueva vacuna basada en mRNA de RBD-hFc de SARS-CoV-2 deliberada en nano partículas de lípidos muestra una ro…
El diseño de una nueva vacuna basada en mRNA de RBD-hFc de SARS-CoV-2 deliberada en nano partículas de lípidos muestra una robusta respuesta inmune. Esta origina anticuerpos neutralizantes y respuesta Th1 en ratones BALB/c. | ACS Nano https://t.co/fGohYwGAhh
RT @peer_lab: We are proud to share our latest contribution to the #Covid_19 mRNA vaccine field. A #SARSCoV2-hFc-Conjugated RBD mRNA Vacc…
RT @peer_lab: We are proud to share our latest contribution to the #Covid_19 mRNA vaccine field. A #SARSCoV2-hFc-Conjugated RBD mRNA Vacc…
RT @peer_lab: We are proud to share our latest contribution to the #Covid_19 mRNA vaccine field. A #SARSCoV2-hFc-Conjugated RBD mRNA Vacc…
We are proud to share our latest contribution to the #Covid_19 mRNA vaccine field. A #SARSCoV2-hFc-Conjugated RBD mRNA Vaccine Delivered via Lipid Nanoparticles @acsnano. https://t.co/yRbrEoehZJ
More on #SARSCoV2 and mRNA #vaccine development: Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles https://t.co/wAUqoNqKdw https://t.co/YefgHZEWA0
[ASAP] Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles https://t.co/MosqhSuLnR